Novo says Wegovy lowered BMI and obesity rates in trial of children under 12
Novo says a trial found Wegovy injections lowered BMI and obesity rates in children; the drug is approved for obesity treatment from age 12, but no medications are currently approved for children under 12.
cnbc.com